BSX · 8-K · 20261028PR000066

Income Tax Rate Changes

BOSTON SCIENTIFIC CORP · 2026-10-28 · Importance 53 · Surprise 64

Third-quarter income tax expense declined to $153 million from $183 million, while the effective tax rate increased to approximately 20.9% from 19.5%. For the first nine months, income tax expense fell to $132 million from $463 million, and the effective rate decreased to approximately 4.5% from 17.2%. The nine-month 2026 results included a $184 million deferred tax benefit, compared with $139 million of deferred tax expense in the prior-year period.

Key facts

• Boston Scientific reported nine-month 2026 income tax expense of $132 million, compared with $463 million in the first nine months of 2025. source
• Boston Scientific reported Q3 2026 income tax expense of $153 million, compared with $183 million in Q3 2025. source